Search

Your search keyword '"Hiatt, Susan"' showing total 212 results

Search Constraints

Start Over You searched for: Author "Hiatt, Susan" Remove constraint Author: "Hiatt, Susan"
212 results on '"Hiatt, Susan"'

Search Results

1. MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway

2. Missense variants in RPH3A cause defects in excitatory synaptic function and are associated with a clinically variable neurodevelopmental disorder

3. Poison exon annotations improve the yield of clinically relevant variants in genomic diagnostic testing

4. Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size (vol 142, pg 2617, 2019)

5. Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size

6. Mutations in MAST1 Cause Mega-Corpus-Callosum Syndrome with Cerebellar Hypoplasia and Cortical Malformations

7. MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway

8. Mutations in EBF3 Disturb Transcriptional Profiles and Cause Intellectual Disability, Ataxia, and Facial Dysmorphism

9. A Genotype/Phenotype Study of KDM5B-Associated Disorders Suggests a Pathogenic Effect of Dominantly Inherited Missense Variants

10. A Genotype/Phenotype Study of KDM5B -Associated Disorders Suggests a Pathogenic Effect of Dominantly Inherited Missense Variants.

11. Long-read genome sequencing and variant reanalysis increase diagnostic yield in neurodevelopmental disorders

12. Current status and new features of the Consensus Coding Sequence database.

13. Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect

14. Variants in TCF20 in neurodevelopmental disability: description of 27 new patients and review of literature

17. De novo mutations in MED13, a component of the Mediator complex, are associated with a novel neurodevelopmental disorder

18. Parents’ Perspectives on the Utility of Genomic Sequencing in the Neonatal Intensive Care Unit

19. 338 The Alabama Genomic Health Initiative: Integrating Genomic Medicine into Primary Care

20. Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype

21. Poison exon annotations improve the yield of clinically relevant variants in genomic diagnostic testing

22. Deleterious, protein-altering variants in the transcriptional coregulator ZMYM3 in 27 individuals with a neurodevelopmental delay phenotype

23. Deleterious, protein-altering variants in the X-linked transcriptional coregulator ZMYM3 in 22 individuals with a neurodevelopmental delay phenotype

24. Deleterious, protein-altering variants in the X-linked transcriptional coregulator ZMYM3 in 22 individuals with a neurodevelopmental delay phenotype

25. Genome sequencing as a first-line diagnostic test for hospitalized infants

28. eP370: SouthSeq: Genome sequencing for a diverse population of hospitalized infants

29. eP141: Expansion of long-read genome sequencing for the molecular diagnosis of neurodevelopmental disorders and multiple congenital anomalies

30. eP425: Parental impact of genome sequencing during the neonatal period

32. Genome sequencing as a first-line diagnostic test for hospitalized newborns

33. RefSeq: an update on mammalian reference sequences

34. Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy

35. The Therapeutic Odyssey: Positioning Genomic Sequencing in the Search for a Child’s Best Possible Life

36. SouthSeq: genome sequencing as a frontline genetic test in the NICU

37. A state-based approach to genomics for rare disease and population screening

39. Long-read genome sequencing for the molecular diagnosis of neurodevelopmental disorders

40. Long-read genome sequencing for the molecular diagnosis of neurodevelopmental disorders

41. De novo TBR1 variants cause a neurocognitive phenotype with ID and autistic traits: report of 25 new individuals and review of the literature

42. Home visiting by paraprofessionals and by nurses: a randomized, controlled trial

43. Long-read genome sequencing for the diagnosis of neurodevelopmental disorders

44. BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder

45. ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder

46. CHARACTERISTICS OF VOLUNTEERS AND FAMILIES IN A NEONATAL HOME VISITATION PROJECT: THE KEMPE COMMUNITY CARING PROGRAM

47. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder

48. Pathogenic WDFY3 variants cause neurodevelopmental disorders and opposing effects on brain size.

49. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder

Catalog

Books, media, physical & digital resources